Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huoxue Zhitong plaster (also known as Huoxue Zhitong Gao) is a topical traditional Chinese medicine (TCM) herbal plaster formulated to invigorate blood circulation, disperse blood stasis, relax tendons, and relieve pain. It is recorded in the Pharmacopoeia of the People's Republic of China (ChP) and is widely manufactured by several pharmaceutical companies in China, including Anhui Anke Yuliangqing Pharmaceutical. The plaster is composed of a complex mixture of multiple herbal extracts and active substances, including dry ginger, Kaempferia galanga, Angelica dahurica, Rheum officinale, Arisaema erubescens, Pinellia ternata, myrrh, frankincense, borneol, menthol, camphor, Angelica sinensis, clove, black pepper, and methyl salicylate, among others. It is approved as an over-the-counter (OTC) drug in China for the treatment of muscle and bone pain, joint soreness, muscle numbness, and traumatic injuries.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Huoxue Zhitong plaster.